Lensar - W/I | 8-K: FY2025 Q3 Revenue Misses Estimate at USD 14.32 M

Revenue: As of FY2025 Q3, the actual value is USD 14.32 M, missing the estimate of USD 17.75 M.

EPS: As of FY2025 Q3, the actual value is USD -0.31, missing the estimate of USD -0.08.

EBIT: As of FY2025 Q3, the actual value is USD -7.713 M.

Segment Revenue

• Total Revenue: $14.3 million for the quarter ended September 30, 2025, an increase of $0.8 million or 6% compared to $13.5 million for the same period in 2024.
• System Revenue: $3.5 million for the quarter ended September 30, 2025, compared to $3.7 million for the same period in 2024.
• Recurring Revenue: $10.8 million for the quarter ended September 30, 2025, compared to $9.9 million for the same period in 2024.

Operational Metrics

• Net Loss: - $3.7 million for the quarter ended September 30, 2025, compared to - $1.5 million for the same period in 2024.
• Selling, General and Administrative Expenses: $12.0 million for the quarter ended September 30, 2025, an increase of $5.9 million or 98% compared to $6.1 million for the same period in 2024.
• Research and Development Expenses: $1.4 million for the quarter ended September 30, 2025, compared to $1.2 million for the same period in 2024.
• EBITDA: - $2.7 million for the quarter ended September 30, 2025, compared to - $0.6 million for the same period in 2024.
• Adjusted EBITDA: - $0.3 million for the quarter ended September 30, 2025, compared to $0.4 million for the same period in 2024.

Cash Flow

• Cash, Cash Equivalents, and Investments: $16.9 million as of September 30, 2025, compared to $22.5 million as of December 31, 2024.

Unique Metrics

• ALLY Systems Installed Base: Increased by 77% to approximately 185 systems as of September 30, 2025, compared to the same period in 2024.
• Total Laser Installed Base: Increased by 20% to approximately 425 systems as of September 30, 2025, compared to the same period in 2024.

Outlook / Guidance

• The company expects the pending acquisition by Alcon to close in the first quarter of 2026, and is working collaboratively with the U.S. Federal Trade Commission regarding the transaction.
• Forward-looking statements include risks related to the completion and benefits of the proposed merger, regulatory approvals, and potential liabilities or costs associated with the merger.